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Increasing amounts of evidence suggests tannic acid (TA) and its derivative, 
gallic acid (GA) has beneficial effects against nephrotoxicity. The aim of this 
study was to investigate the effect of TA and GA (two structurally related 
phenolic acids) against cisplatin-induced thiobarbituric acid reactive 
substances (TBARS) production in rat kidney in vitro. The effect of both 
phenolic acids on kidney TBARS level in the presence of cisplatin, an anti-
neoplastic drug used in the treatment of many solid-tissue cancers which has 
its chief side effect in nephrotoxicity, was assessed. Thereafter, the 
antioxidant properties were also determined. Incubation of the kidney tissue 
homogenate in the presence of cisplatin (1 mM) caused a significant 
(P<0.05) increase in the TBARS level. However, both phenolic acids caused 
a significant (P<0.05) decrease in the TBARS content of the kidney in a dose 
dependent manner (0 – 12.5 µM). Nevertheless, TA had a significantly 
higher (P<0.05) inhibitory effect on TBARS production than gallic acid 
judging by their IC50 value. Furthermore, TA possesses stronger antioxidant 
properties than GA as revealed by their scavenging, chelating and reducing 
ability. The inhibition of cisplatin–induced thiobarbituric acid reactive 
substances (TBARS) production in rat kidney by both TA and GA could be 
due to their antioxidant properties and this provide further insight into the 
mechanism of action for their nephroprotective properties from previous 
reported experimental studies. However, the study revealed that hydrolysis of 
TA reduces its potency. 
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INTRODUCTION  
The use of chemotherapy in the treatment of cancer has opened new possibilities for improvement of the quality of 
life of cancer patients. Despite its success, treatment with some of the most effective anticancer drugs shows a 
number of symptoms of direct toxicity. Additionally, many anticancer drugs have been shown to be mutagenic, 
teratogenic, and carcinogenic in experimental systems. Second malignancies are also known to be associated with 
several therapeutic treatments [1].   
Cisplatin (cis-diamminedichloroplatinum(II), CP) is an antitumor drug commonly used in the treatment of testicular, 
ovarian, bladder, cervical, esophageal, head and neck and small cell lung cancer [2]. Unfortunately, numerous side 
effects are related to CP therapy, including ototoxicity, gastrointestinal toxicity, myelosuppression, neurotoxicity 
and kidney injury [3,4]. Kidneys represent the main route of CP excretion, with proximal tubule cells as a primary 
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site of CP accumulation [5]. Thus, nephrotoxicity is one of the most serious dose-limiting side effects in CP 
chemotherapy. The major mechanisms of CP-induced nephrotoxicity include tubular necrosis, oxidative stress, 
inflammation and apoptosis [3]. Studies using chemiluminescence or electron spin resonance (ESR) have shown that 
CDDP generates OH radical [1]. A number of strategies have been proposed for the prevention/management of 
cisplatin-induced nephrotoxicity since there is no specific treatment, with the use of some synthetic drugs been 
popular. However, these drugs have some associated risks and side-effects [6], hence the need for natural 
alternatives of plant origin (plant foods/extracts) with little or no side effect.  
In recent years, human health has assumed an unprecedented important status. A new diet-health paradigm is 
everlasting which places more emphasis on the positive aspects of diet. Foods have now assumed the status of 
functional foods, which should be capable of providing additional physiological benefit, such as prevent or delaying 
onset of chronic diseases, as well as meeting basic nutritional requirements [7]. Recent reports revealed that a 
practical approach to the management / prevention of diseases that are associated with oxidative stress is through 
dietary means, which involves eating foods that are rich in antioxidants [7,8]. Apart from vitamin C and E that are 
already established food nutrient with antioxidant properties, plant phenolics among them phenolic acids, which are 
known to be scavengers of various oxygen species have been shown to be more potent [9,10]. The efficiency of 
phenolic compounds as anti-radicals and antioxidants is diverse and depends on many factors, such as the number of 
hydroxyl groups bonded to the aromatic ring, the site of bonding and mutual position of hydroxyls in the aromatic 
ring. For example, Rice-Evans et al. [11] and Joyeux et al. [12] described the advantageous effect of an ortho-
hydroxyl substitution in the aromatic ring for the anti-radical and antioxidant activity of phenolic acids.  
Tannic acid (TA), a naturally occurring plant polyphenol, is composed of a central glucose molecule derivatized at 
its hydroxyl groups with one or more galloyl residues (Figure 5). Gallic acid (GA), also known as 3,4,5-
trihydroxybenzoic acid, is a monomer or derivative of tannic acid upon hydrolysis (Figure 5). Both TA and GA is 
one of the most important polyphenolic substances in plants which is present in grapes, different berries, mango, 
areca nut, walnut and other fruits as well as in several beverages including red wine, beer, coffee, black tea, green 
tea, and many foodstuffs such as sorghum, black-eyed peas, lentils and chocolate [13,14]. Similar to many phenolic 
acids, both TA and GA have been shown to possess antioxidant [15,16] anti-inflammatory [16], anti-mutagenic 
[17,18] and anti-carcinogenic properties [18-20]. In vitro studies revealed that tannic acid inhibited the proliferation 
of various cancer cell lines and induced cancer cell apoptosis [18-20]. Recently, they have been shown to possess 
renoprotective potential against cisplatin-induced kidney injury [21,22]. Based on this, it is expedient to compare the 
protective effect of both TA and GA against cisplatin-induced TBARS production in vitro in order to provide further 
mechanism of action for their beneficial effects against nephrotoxicity and to reveal which phenolic acid is more 
potent. 
 
Materials and methods 
Chemicals 
Chemicals such as caffeic acid, chlorogenic acid, thiobarbituric acid (TBA), and 1,1-diphenyl-2-picrylhydrazyl 
(DPPH) were purchase from Sigma-Aldrich, Chemie GmH (Steinheim, Germany), Tris-HCl buffer, sodium dodecyl 
sulphate (SDS) and acetic acid were procured from BDH Chemical Ltd., (Poole, England). Pharmaceutical grade 
Cisplatin (CP) under the brand name „Cytoplatin50‟ was purchased from Cipla Ltd., India. Except otherwise stated, 
all other chemicals and reagents are of analytical grade while the water was glass distilled. 
Lipid peroxidation assay 
Experimental animals  
Male Wistar albino rats weighing 190–250 g were purchased from the Central Animal House, Department of 
Biochemistry, University of Ilorin, Ilorin, Nigeria. They were housed in stainless steel cages under controlled 
conditions with a 12-hour/12-hour light/dark cycle, 50% humidity, and temperature of 28°C. The rats were allowed 
ad libitum access to food and water. The animals were handled in accordance with NIH Guide for the care and use 
of laboratory animals.  
Preparation of tissue homogenates 
The rats were decapitated under mild diethyl ether anaesthesia, and the kidney tissue was rapidly dissected and 
placed on ice and weighed. This tissue was subsequently homogenized in cold saline (1:10 w/v) with about 10 up-
and-down strokes at approximately 1200 revolutions/min in a Teflon glass homogenizer (Mexxcare, mc14 362, 
Aayushi Design Pvt. Ltd., New Delhi, India). The homogenate was centrifuged (KX3400C Kenxin International 
Co., Hong Kong) for 10 minutes at 3000 g to yield a pellet that was discarded and a low-speed supernatant, which 
was kept for lipid peroxidation assay [23]. 
Lipid peroxidation and thiobarbibutric acid reactions 
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The lipid peroxidation assay was carried out by using the modified method of Ohkawa et al. [24]. Briefly, 100 µL of 
the supernatant fraction was mixed with a reaction mixture containing 30 µL of 0.1M Tris-HCl buffer (pH, 7.4), 
phenolic acids (0 – 100 μM) and 30 µL of 1mM cisplatin. The volume was made up to 300 µL with water before 
incubation at 37
o
C for 1h. The color reaction was developed by adding 300 µL 8.1% SDS (sodium dodecyl sulphate) 
to the reaction mixture containing supernatant; this was subsequently followed by the addition of 600 µL of acetic 
acid/HCl (pH, 3.4) mixture and 600 µL of 0.8% TBA (thiobarbituric acid). This mixture was incubated at 100°C for 
1 hour. The TBARS produced were measured at 532 nm and expressed as MDA produced (% control) by using the 
MDA standard curve (0 – 0.035 mM). 
DPPH free radical scavenging ability 
The free radical scavenging ability of the phenolic acids against DPPH free radical was evaluated as described by 
Gyamfi et al. [25]. Briefly, an appropriate dilution of the acids (1 mL) was mixed with 1 mL 0.4 mM methanolic 
solution containing DPPH radicals. The mixture was left in the dark for 30 minutes, and the absorbance was taken at 
516 nm. The control was carried out by using 2 mL DPPH solution without the test samples. The DPPH free radical 
scavenging ability was subsequently calculated as follows:  
DPPH scavenging ability (%) = [(AbsControl - AbsSamples)/AbsControl]*100 
Determination of Fe
2+ 
chelating ability 
The Fe
2+
 chelating ability of the tannic and gallic acids was determined using a modified method of Minotti and 
Aust [26], with a slight modification by Puntel et al. [27]. Freshly prepared 500 μM FeSO4 (150 μL) was added to a 
reaction mixture containing 168 μL of 0.1 M Tris-HCl (pH 7.4), 218 μL saline and the phenolic acids (0 – 10 μM). 
The reaction mixture was incubated for 5 min, before the addition of 13 μL of 0.25% 1,10 phenanthroline (w/v). The 
absorbance was subsequently measured at 510 nm in a spectrophotometer. The Fe
2+
 chelating ability was 
subsequently calculated. 
Determination of reducing power  
The reducing property of the acids was determined by assessing their ability to reduce FeCl3 solution as described 
by Oyaizu [28]. A 500 µL aliquot of the phenolic acids was mixed with 2.5 mL of 200 mM sodium phosphate buffer 
(pH 6.6) and 2.5 mL of 1% potassium ferricyanide. The mixture was incubated at 50
o
C for 20 min and then 2.5 mL 
of 10% trichloroacetic acid was added. This mixture was centrifuged at 801 × g for 10 min. 5 mL of the supernatant 
was mixed with an equal volume of water and 1 mL of 0.1% ferric chloride. The absorbance was measured at 700 
nm and ferric reducing power was subsequently calculated using ascorbic acid equivalent. 
Statistical Analysis 
Statistical analysis was performed using statistical program for social science (SPSS) 16.0 (SPSS. Inc. Chicago, 
Illinois, USA). Results were represented as mean ± SD, and the differences were analyzed using one-way analysis of 
variance (ANOVA) followed by the Duncan‟s multiple range analysis. A p value < 0.05 was considered to be 
statistically significant. 
 
Results  
As presented in Figure 1, incubation of the kidney homogenate in the presence of cisplatin (1 mM) caused a 
significant (P<0.05) increase in the TBARS content. However, the introduction of both tannic acid and gallic acid (0 
– 12.5 µM) caused a dose-dependent significant (P < 0.05) decrease in the TBARS level of the cisplatin stressed 
kidney homogenates with tannic acid (IC50 = 8.7 µM) exhibiting higher inhibitory effect than gallic acid (IC50 = 17.8 
µM) as revealed by their IC50 value (Table 1). 
Furthermore, the phenolic acids were able to scavenge DPPH free radical in a dose-dependent manner (0 – 100 µM) 
as shown in Figure 2. However, tannic acid (IC50 = 74.6 µM) had a significantly higher scavenging ability than 
gallic acid (IC50 = 105.2 µM) (Table 1). 
In addition, both tannic acid and gallic acid exhibited chelating property by their ability to chelate metal such as Fe
2+
 
in a dose dependent manner (0 – 10 µM) as shown in Figure 3. However, tannic acid (IC50 = 2.5 µM) had better Fe
2+
 
chelating ability than gallic acid (IC50 = 3.2 µM) (Table 2). 
Figure 4 revealed the ferric reducing antioxidant properties of both tannic acid and gallic acid expressed as ascorbic 
acid equivalent (AAE). The results revealed also that tannic acid (11.1 mmol. AAE/g) had significantly higher (P < 
0.05) reducing power than gallic acid (3.4 mmol. AAE/g).  
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TABLE 1: IC50 (inhibitor concentration causing 50% inhibition) value of cisplatin induced MDA production, DPPH 
radical scavenging and Fe
2+
 chelating abilities of gallic and tannic acids 
 
      Gallic acid  Tannic acid   
 
Cisplatin induced MDA production (µM) 17.8
a
 ± 2.4   8.7
b
 ± 1.3  
DPPH radical scavenging ability (µM) 105.2
c
 ± 5.2   74.6
b
 ± 2.0 
Fe
2+
 chelating ability (µM)  3.2
a
 ± 0.10   2.5
b
 ± 0.08 
 
 
Values represent mean ± standard deviation of triplicate experiments 
Values with the same superscript letter along the same row are not significantly different (P<0.05) 
 
 
 
 
 
 
FIGURE 1: Inhibition of cisplatin induced lipid peroxidation in rat kidney by gallic and tannic acids. 
Values represent mean ± standard deviation of triplicate experiments 
Different letters above each concentration indicate significant differences (P < 0.05).  
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FIGURE 2: DPPH free radical scavenging ability of gallic and tannic acids 
Values represent mean ± standard deviation of triplicate experiments 
Different letters above each concentration indicate significant differences (P < 0.05).  
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FIGURE 3: Fe
2+
 chelating ability of gallic and tannic acids 
Values represent mean ± standard deviation of triplicate experiments 
Different letters above each concentration indicate significant differences (P < 0.05).  
 
 
 
 
 
 
ISSN 2320-5407                              International Journal of Advanced Research (2015), Volume 3, Issue 1, 116-126 
122 
 
 
FIGURE 4: Ferric reducing antioxidant property (FRAP) of gallic and tannic acids 
Values represent mean ± standard deviation of triplicate experiments 
Bars with different letters indicate significant differences (P < 0.05).  
 
 
 
 
 
 
A.        B. 
 
FIGURE 5: Chemical structures of used phenolic acids (A) Tannic acid and (B) Gallic acid 
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Discussion 
Oxidative stress plays a critical role in the pathophysiology of CP-induced kidney injury [21]. Lipid peroxidation is 
a hallmark of oxidative stress in the cell [29,30]. Lipid peroxidation is another process that produces many 
pathological events in the cells and the organism of man [29-32]. This process, causing damage to unsaturated fatty 
acids, tends to decrease membrane fluidity and leads to many other pathological events. Previous studies showed 
increased lipid peroxidation in the kidneys after CP administration which was markedly attenuated by natural 
antioxidants, including hesperidin, carnosic acid, apocynin and cannabidiol [33-36].  
In this present study, incubation of the kidney tissue homogenate in the presence of cisplatin (1 mM) caused a 
significant (P<0.05) increase in the TBARS content (Figure 1). This result agrees with a recent work reported by 
Oboh et al. [37] where cisplatin has been shown to induce lipid peroxidation in rat tissue. In addition, Pabla et al. 
[38] and Jiang et al. [39] reported CP-induced renal cell apoptosis both under in vitro and in vivo conditions. The 
increased lipid peroxidation in the presence of cisplatin could be attributed to the fact that it can catalyze one-
electron transfer reactions that generate reactive oxygen species, such as the reactive OH•, which is formed from 
H2O2 through the Fenton reaction. However, both phenolic acids caused a significant (P<0.05) decrease in the 
TBARS content of the kidney in a dose dependent manner. Nevertheless, as revealed by their IC50 (inhibitor 
concentration causing 50% inhibition of TBARS level) value, tannic acid had a significantly higher (P<0.05) 
inhibitory effect than gallic acid (Table 1).  
Furthermore, the mechanisms through which the phenolic acids prevent cisplatin-induced lipid peroxidation were 
subsequently evaluated by determining their antioxidant properties. Antioxidants carry out their protective properties 
on cells either by preventing the production of free radicals or by neutralizing free radicals produced in the body 
[40]. Prevention of the chain initiation step by scavenging various reactive species such as free radicals is considered 
to be an important antioxidant mode of action [41]; hence, the ability of the phenolic acids to scavenge DPPH free 
radical was assessed in this study. This is based on a model system whereby antioxidant capacity is measured by the 
ability to donate a hydrogen atom thereby neutralizing DPPH radicals. DPPH is a free radical donor that accepts an 
electron or hydrogen to become a stable diamagnetic molecule [42]. The tendencies of electron or hydrogen 
donation are critical factors in characterizing antioxidant activity that involves free radical scavenging [42]. The 
result presented in Figure 2 revealed that both gallic and tannic acids scavenge DPPH radical in a dose dependent 
manner. However, judging by their IC50 value (Table 1), tannic acid had a significantly (P<0.05) higher DPPH 
radical scavenging ability than gallic acid. The higher radical scavenging ability of tannic acid could be due to the 
number of hydroxyl groups more than gallic acid with only three hydroxyl groups bonded to the aromatic ring in an 
ortho position as shown in Figure 5. Rice-Evans et al. [11] reported that the position and number of hydroxyl group 
in phenolic compounds influence their antioxidant properties. 
Furthermore, the ability of antioxidants to chelate and deactivate transition metals, prevent such metals from 
participating in the initiation of lipid peroxidation and oxidative stress through metal catalysed reaction [43]. Iron 
(Fe), an essential metal needed for normal cellular physiology is present in biological systems bound to several 
protein moieties such as heamoglobin, ferritin etc. It may also exist in free forms in which it is able to participate in 
Fenton reaction with hydroxyl radical and Fe
3+
 as products. Chelation of such transition metals such as Fe is 
regarded as a preventive antioxidant mechanism. Our result revealed that both phenolic acids were able to chelate 
Fe
2+
 in a dose-dependent manner. However, judging by their IC50 value (Table 1), tannic acid had a significantly 
(P<0.05) higher Fe
2+
 chelating ability than gallic acid. This Fe
2+
 chelating ability of the acids is of immense 
importance in the protective ability of antioxidant phytochemicals against oxidative stress, as this will make free Fe 
biologically unavailable thereby inhibiting its role in activating free radicals. However, the Fe
2+
 chelating ability of 
the phenolic acids could be attributed to the presence of the following functional groups: -OH and -COOH in a 
favourable structure–function configuration [44,45].  
Reducing power is a novel antioxidation defence mechanism; the two mechanisms available to affect this property 
are by electron transfer and hydrogen atom transfer [46]. This is because the ferric-to-ferrous ion reduction occurs 
rapidly with all reductants with half reaction reduction potentials above that of Fe
3+
/Fe
2+
, the values in the Ferric 
reducing antioxidant property (FRAP) assay will express the corresponding concentration of electron-donating 
antioxidants [47]. The result revealed that tannic acid had significantly higher (P<0.05) reducing power than gallic 
acid. Since the antioxidant activity of phenolics is mainly due to their redox properties, this allows them to act as 
reducing agents, hydrogen donors and singlet oxygen quenchers [11]. The higher reducing power of the tannic acid 
agrees with the other antioxidant properties carried out in Figure 3 and 4. This confirm that the functional groups 
such as the number of the hydroxyl group influence their antioxidant property as previously reported by Rice-Evans 
et al. [11]. 
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Conclusion 
In conclusion, both TA and GA inhibited cisplatin–induced thiobarbituric acid reactive substances (TBARS) 
production in rat kidney in a dose-dependent manner in vitro. This inhibitory effect could be due to their antioxidant 
properties as typified by their DPPH radical scavenging, Fe
2+
 chelating and reducing abilities. Furthermore, this 
study provide further insight into the mechanism of action for their nephroprotective properties from previous 
reported experimental studies and confirm their antioxidant potential. However, tannic acid possesses better 
antioxidant properties than gallic acid which could be due to the number of functional groups present indicating that 
hydrolysis affects its potency.  
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